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INTRODUCTION
The narrow host range of human immunodefi-
ciency virus type 1 (HIV-1) has been a major obsta-
cle for establishing the animal model system for
studies of viral replication and pathogenesis in vivo
(1). HIV-1 infects and causes disease only in hu-
mans. To conquer this difficulty, we have recently
generated a monkey-tropic HIV-1 designated NL-
DT5R (1-3). Its genome contains a gag sequence en-
coding simian immunodeficiency virus from rhesus
monkeys (SIVmac) capsid (CA) element, corre-
sponding to the HIV-1 cyclophilin A (CypA) - bind-
ing loop, and the entire SIVmac vif gene (2). How-
ever, by subsequent studies, NL-DT5R was found
to grow in simian cells more poorly both in vitro and
in vivo than a standard SIVmac designated SIVmac
239, which induces the AIDS in monkeys and is
widely used for model studies of HIV-1/AIDS. As a
result of its biological property, NL -DT5R was un-
able to induce AIDS in the animals (3). Extensive at-
tempts to improve the growth ability of NL-DT5R in
simian cells through modification of Gag-CypA re-
gion and Vif by recombinant DNA techniques have
been so far unsuccessful (4, 5). Another research
group has also reported that a monkey cell-tropic
HIV-1 designated stHIV-1 is successfully generated
by genetic manipulation and virus adaptation in cells
(6). It was suggested that three amino acid muta-
tions in gag might be important for the ability of
HIV-1 to grow in simian cells (6).
In this study, to potentiate growth capability in
simian cells of a prototype monkey-tropic HIV-1
clone, various SIVmac sequences and mutations
were introduced into the gag of NL-DT5R, and the
resultant recombinants/mutants were monitored for
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their growth properties in simian HSC-F cells. We
show here clearly that any viruses without the
SIVmac CypA region do not grow in HSC-F cells,
and demonstrate the importance of CypA region for
the species tropism of HIV-1.
MATERIALS AND METHODS
Cells
A human monolayer cell line 293T (7) was main-
tained in Eagles’s minimal essential medium con-
taining 10% heat-inactivated fetal bovine serum. A
simian lymphocytic cell line HSC-F (8) was main-
tained in RPMI-1640 medium containing 10% heat-
inactivated fetal bovine serum.
Transfection
Sub-confluent 293T cells in 90 mm dishes were
transfected with 20 μg of proviral clones by the cal-
cium-phosphate co-precipitation method, and on
day 2 post-transfection, cell-free virus samples for
infection experiments were prepared as previously
described (9).
Infection
HSC-F cells (1-10106) were infected with an
equal amount of viruses [1-10106 reverse tran-
scriptase (RT) units] prepared from transfected
293T cells, and monitored for RT production at in-
tervals as previously described (9).
RT assay
Virus production in transfected 293T cells and vi-
ral growth property in infected HSC-F cells were de-
termined by monitoring RT activity of the culture su-
pernatants. RT assay using 32P-dTTP has been pre-
viously described (10).
DNA constructs
Full-length infectious molecular clones of HIV-1
and SIVmac, designated pNL4-3 (9) and pMA239
(11), respectively, have been previously described.
A monkey- tropic infectious DNA clone of HIV-1
designated NL-DT5R has been previously described
(2). An infectious clone designated NL-DT5R/4-3 is
a derivative of NL-DT5R carrying CA of NL4-3, and
grows more poorly than NL-DT5R in simian HSC-F
cells (4). Various gag recombinants and mutants of
NL-DT5R were constructed by the QuikChange
site-directed mutagenesisi kit (Stratagene, La Jolla,
CA, USA) as previously described (12).
RESULTS AND DISCUSSION
Our previous results have indicated that modifi-
cations in gag (encoding CypA-binding loop) and
vif genes of NL-DT5R do not improve its growth
ability in simian cells (4, 5). We, therefore, con-
structed new gag recombinants between NL-DT5R
and MA239 of SIVmac to obtain HIV-1 type viruses
which would be more replication-competent than
NL-DT5R in simian cells. We previously reported
that recombinants between HIV-1 NL4-3 and SIVmac
MA239 within five regions of CA-p2 are viable and
infectious for human M8166 cells (12). Based on
these results, recombinants in this study were
carefully designed as shown in Fig. 1 and Table 1.
To examine growth potentials in simian cells of new
viral clones (10 clones in Fig. 1 and Table 1), they
were transfected into 293T cells, and cell-free virus
samples were prepared on day 2 post-transfection. Vi-
ruses obtained were then inoculated into HSC-F
cells, and viral growth was monitored by RT assay.
Representative results are shown in Fig. 2 and all
the data are summarized in Table 1. As shown in
Fig. 2, NL-DT5R readily established a spreading in-
fection albeit grew more poorly than SIVmac239.
The peak infection day for SIVmac239 and NL-DT
5R were 6 and 18, respectively. In contrast to NL-
DT5R, eight of ten recombinants (Fig. 1 and Table
1) were not infectious at all for HSC-F cells (Fig. 2
Figure 1 Structure of Gag CA-p2 region of various recombi-
nant clones derived from a monkey-tropic HIV-1 NL-DT5R. Se-
quences of SIVmac239 are indicated by black areas (for details,
see Table 1). Structural domains of HIV-1 Gag CA-p2 (19, 20)
are shown at the top. Amino acid sequence PQPAPQQ represents
the region of SIVmac239 corresponding to the CypA-binding loop
of HIV-1 CA (PVHAGPIAP). H, α -helix.
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and Table 1). Even the two infectious recombinants
(CS47 and CS86/100) did not grow better than NL-
DT5R. In particular, CS47, which actually is a point
mutant of NL-DT5R, grew much more poorly than
NL-DT5R similarly with DT5R/4-3 carrying the
HIV-1 type CA (4).
Recently, Hatziioannou, et al. reported that their
monkey cell-tropic HIV-1 designated stHIV-1 differs
from the parental HIV-1 clone in only minor ways
other than the genetically engineered CA and Vif
substitutions (6). They found three coding muta-
tions in gag (K110I, A209V and P371L) and six si-
lent mutations in gag and pol (6). Based on this re-
port, we introduced the three nonsynonymous mu-
tations into NL-DT5R to have viral clones that would
grow better than NL-DT5R in simian cells (Fig. 3A).
Table 1. Amino acid sequences of SIVmac inserted into CA-p2 region of NL-DT5R, a derivative of HIV-1 NL4-3
Recombinants Amino acid sequences of MA239 inserted1 Growth in HSC-F cells
CS13/15 (13) PLS (15) (-)
CS47 (47) T (47) (+)
CS86/100 (86) PQPAPQQGQLREPSGSD (100) (+)
CS86/122 (86) PQPAPQQGQLREPSGSDIAGTTSSVDEQIQWMYRQQNPI (122) (-)
CS110/112-119/122 (110) EQI (112) (-)
(119) YRQQN (122)
CS119/122 (119) YRQQN (122) (-)
CS153/215 (153) QGPKEPFQSYVDRFYKSLRAEQTDAA (-)
VKNWMTQTLLIQNANPDCKLVLKGLGVNPTL
EEMLTA (215)
CS207/209 (207) PTL (209) (-)
CS235/245-f (235) LKEALAPVPIPFAA (245) (-)
CS238/240 (238) APV (240) (-)
1The first and last amino acid numbers of HIV-1 NL4-3 CA-p2 replaced with sequences of SIVmac MA239 are indicated in parenthe-
ses. GenBank accession numbers for pNL4-3 and pMA239 are AF324493 and M33262, respectively.
Figure 2 Growth kinetics in HSC-F cells of Gag CA-p2 recom-
binants. Input cell - free viral samples were prepared from 293T
cells transfected with the clones indicated, and an equivalent RT
units were inoculated into HSC-F cells. Viral growth was moni-
tored at intervals by RT activity in the culture supernatants. As
a negative control (Cr), pUC19 was used.
A
B
C
Figure 3 Growth kinetics in HSC-F cells of Gag mutants. (A)
Locations of mutations in Gag. Mutations at the indicated positions
are introduced into NL-DT5R and NL4-3 (mutants in panels B
and C, respectively). Amino acid sequence PQPAPQQ represents
the region of SIVmac239 corresponding to the CypA-binding loop
of HIV-1 CA (PVHAGPIAP). MA, Gag matrix protein ; NC, Gag
nucleocapsid protein ; SP1 and SP2, Gag spacer proteins 1 (p2)
and 2 (p1), respectively. (B) and (C) Growth kinetics of various
mutants clones in HSC-F cells were determined as described in
the legend to Fig. 2. Results obtained in one experiment are
shown separately in (B) and (C) for clarity.
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Proviral clones containing each and all the three mu-
tations were constructed for this purpose. Cell- free
virus samples derived from these clones were pre-
pared as described above, and inoculated into HSC-
F cells. As shown in Fig. 3B, while control viruses
SIVmac239 and NL-DT5R grew in a consistent man-
ner, two (A209V and P371L) out of the four mutants
displayed retarded growth phenotype. Although K
110I grew similarly well with NL-DT5R, the triple
mutant K110I/A209V/P371L did not at all. To know
whether the three mutations can confer the ability
to grow in simian cells on HIV-1 type CA, four mu-
tant clones in the context of NL4-3 were constructed
as above and monitored for their growth potentials
in HSC-F cells. As clearly seen Fig. 3C, the growth
of the four mutants were undetectable or negligible
during the observation period, indicating the re-
ported coding mutations in gag (6) are biologically
inactive or meaningless in simian cells.
In this study, we have constructed ten new recom-
binants between the NL-DT5R clone of monkey-
tropic HIV-1 and the standard pathogenic clone
SIVmac239, and four new gag mutants of NL-DT5R
in anticipation of improved growth potentials in sim-
ian cells. In addition to the changes relative to HIV-1
(Gag -CypA region and Vif) which the prototype
monkey-tropic virus NL-DT5R carries, the new vi-
ral clones contain alterations in scattered regions of
Gag-CA and in the other parts of Gag. Our results
here clearly showed that region(s) around the CypA-
binding loop of HIV-1 is critical for viral growth abil-
ity in simian cells. Cellular TRIM5α is well known to
interact with this region and restrict retroviral rep-
lication (13-18). In this regard, it is interesting to
note that NL-DT5R does not overcome the barrier
imposed by TRIM5α (4). Virological studies to
evade the TRIM5α restriction are in progress in our
laboratory.
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